Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Seiji Fukumoto  (Fukumoto S) 1 Article
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
Seiji Fukumoto
Endocrinol Metab. 2014;29(2):136-143.   Published online June 26, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.2.136
  • 3,230 View
  • 39 Download
  • 24 Citations
AbstractAbstract PDFPubReader   CrossRef-TDMCrossref - TDM

Fibroblast growth factor 23 (FGF23) is a hormone that is produced by osteocytes and regulates phosphate and vitamin D metabolism through binding to the Klotho-FGF receptor complex. Excessive actions of FGF23 cause several kinds of hypophosphatemic rickets/osteomalacia. Tumor-induced rickets/osteomalacia (TIO) is a paraneoplastic syndrome caused by overproduction of FGF23 from the responsible tumors. Because TIO is cured by complete resection of the causative tumors, it is of great clinical importance to locate these tumors. Several imaging methods including skeletal survey by magnetic resonance imaging and octreotide scintigraphy have been used to identify the tumors that cause TIO. However, none of these imaging studies indicate that the detected tumors are actually producing FGF23. Recently, systemic venous sampling was conducted for locating FGF23-producing tumor in suspected patients with TIO and demonstrated that this test might be beneficial to a subset of patient. Further studies with more patients are necessary to establish the clinical utility of venous sampling in patients with TIO.

Citations

Citations to this article as recorded by  
  • Tumor-induced Osteomalacia: A Systematic Review and Individual Patient’s Data Analysis
    Domenico Rendina, Veronica Abate, Giuseppe Cacace, Lanfranco D’Elia, Gianpaolo De Filippo, Silvana Del Vecchio, Ferruccio Galletti, Alberto Cuocolo, Pasquale Strazzullo
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(8): e3428.     CrossRef
  • Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice
    Zhousheng Xiao, Jiawang Liu, Shih-Hsien Liu, Loukas Petridis, Chun Cai, Li Cao, Guangwei Wang, Ai Lin Chin, Jacob W. Cleveland, Munachi O. Ikedionwu, Jesse D. Carrick, Jeremy C. Smith, Leigh Darryl Quarles
    Molecular Pharmacology.2022; 101(6): 408.     CrossRef
  • Identification of Small-Molecule Inhibitors of Fibroblast Growth Factor 23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-Klotho
    Shih-Hsien Liu, Zhousheng Xiao, Sambit K. Mishra, Julie C. Mitchell, Jeremy C. Smith, L. Darryl Quarles, Loukas Petridis
    Journal of Chemical Information and Modeling.2022; 62(15): 3627.     CrossRef
  • Osteomalacia oncogénica secundaria a tumor mesenquimal fosfatúrico del pie
    Sandra Garrote-Corral, Walter Alberto Sifuentes-Giraldo, María Eugenia Reguero-Callejas, Mónica Vázquez-Díaz
    Revista Colombiana de Reumatología.2020; 27(3): 210.     CrossRef
  • Hypophosphataemic Rickets: Similar Phenotype of Different Diseases
    Francisco de la Cerda-Ojeda, Juan D. González-Rodríguez, Leire Madariaga, Guillermo Martínez-Díaz-Guerra, María L. Matoses-Ruipérez
    Advances in Therapy.2020; 37(S2): 80.     CrossRef
  • Oncogenic osteomalacia secondary to phosphaturic mesenchymal tumor of the foot
    Sandra Garrote-Corral, Walter Alberto Sifuentes-Giraldo, María Eugenia Reguero-Callejas, Mónica Vázquez-Díaz
    Revista Colombiana de Reumatología (English Edition).2020; 27(3): 210.     CrossRef
  • Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review
    Nitish Agarwal, ShashankS Kale, Kalpana Kumari
    Neurology India.2019; 67(5): 1334.     CrossRef
  • Review of paraneoplastic syndromes in children
    Grace MY. Ma, Jeanne S. Chow, George A. Taylor
    Pediatric Radiology.2019; 49(4): 534.     CrossRef
  • Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report
    Yanying Qian, Zhijuan Dai, Cong Zhu, Luya Ruan, Saroj Thapa, Chaoming Wu
    Journal of International Medical Research.2019; 47(5): 2240.     CrossRef
  • Osteomalazie – Klinik, Diagnostik und Therapie
    M. Tiefenbach, M. Scheel, A. Maier, M. Gehlen, M. Schwarz-Eywill, M. Werner, U. Siebers-Renelt, M. Hammer
    Zeitschrift für Rheumatologie.2018; 77(8): 703.     CrossRef
  • Tumor-induced osteomalacia caused by a massive phosphaturic mesenchymal tumor of the acetabulum: A case report
    Kimitaka Nakamura, Masanobu Ohishi, Tomoya Matsunobu, Yasuharu Nakashima, Akio Sakamoto, Akira Maekawa, Yoshinao Oda, Yukihide Iwamoto
    Modern Rheumatology.2018; 28(5): 906.     CrossRef
  • A case report of phosphaturic mesenchymal tumor-induced osteomalacia
    Weiqian Wu, Chongyang Wang, Jianwei Ruan, Feng Chen, Ningjun Li, Fanghu Chen
    Medicine.2017; 96(51): e9470.     CrossRef
  • Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23
    Ji-Yeon Lee, Hye-Sun Park, Seunghee Han, Jiyu Kelly Lim, Namki Hong, Sung Il Park, Yumie Rhee
    Yonsei Medical Journal.2017; 58(5): 981.     CrossRef
  • Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones
    Hiroshi Kobayashi, Toru Akiyama, Tomotake Okuma, Yusuke Shinoda, Hiroyuki Oka, Nobuaki Ito, Seiji Fukumoto, Sakae Tanaka, Hirotaka Kawano
    Computer Assisted Surgery.2017; 22(1): 14.     CrossRef
  • Effective localization in tumor-induced osteomalacia using 68Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI
    Shintaro Kawai, Hiroyuki Ariyasu, Yasushi Furukawa, Reika Yamamoto, Shinsuke Uraki, Ken Takeshima, Kenji Warigaya, Yuji Nakamoto, Takashi Akamizu
    Endocrinology, Diabetes & Metabolism Case Reports.2017;[Epub]     CrossRef
  • Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia
    Hiroshi Kobayashi, Nobuaki Ito, Toru Akiyama, Tomotake Okuma, Yuka Kinoshita, Masachika Ikegami, Yusuke Shinoda, Seiji Fukumoto, Sakae Tanaka, Hirotaka Kawano
    International Orthopaedics.2017; 41(12): 2597.     CrossRef
  • Osteomalacia tumoral: un síndrome paraneoplásico emergente
    Guillermo Alonso, Mariela Varsavsky
    Endocrinología y Nutrición.2016; 63(4): 181.     CrossRef
  • Tumour-induced osteomalacia: An emergent paraneoplastic syndrome
    Guillermo Alonso, Mariela Varsavsky
    Endocrinología y Nutrición (English Edition).2016; 63(4): 181.     CrossRef
  • FGFs: crucial factors that regulate tumour initiation and progression
    Qian Jing, Yuanyuan Wang, Hao Liu, Xiaowei Deng, Lin Jiang, Rui Liu, Haixing Song, Jingyi Li
    Cell Proliferation.2016; 49(4): 438.     CrossRef
  • Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir
    Rikako Hiramatsu, Yoshifumi Ubara, Naoki Sawa, Eiko Hasegawa, Masahiro Kawada, Aya Imafuku, Keiichi Sumida, Junichi Hoshino, Kenmei Takaichi
    Internal Medicine.2016; 55(20): 3013.     CrossRef
  • Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: A case report and review of the literature
    Ejigayehu G. Abate, Victor Bernet, Cherise Cortese, Hillary W. Garner
    Bone Reports.2016; 5: 81.     CrossRef
  • Tumor-Induced Osteomalacia: an Up-to-Date Review
    Anke H. Hautmann, Matthias G. Hautmann, Oliver Kölbl, Wolfgang Herr, Martin Fleck
    Current Rheumatology Reports.2015;[Epub]     CrossRef
  • Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia
    Meghan Higley, Brooke Beckett, Sandra Schmahmann, Elizabeth Dacey, Erik Foss
    Skeletal Radiology.2015; 44(12): 1825.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef

Endocrinol Metab : Endocrinology and Metabolism